Narcotic Antagonists (Advances in Biochemical Psycho-pharmacology 8)
, 1975 Robert L. DuPont
openalex +1 more source
Exploring the Potential of a P2X3 Receptor Antagonist: Gefapixant in the Management of Persistent Cough Associated with Interstitial Lung Disease. [PDF]
Medicina (Kaunas)Takahashi T +5 more
europepmc +1 more source
Time Course of Reversal of Fentanyl-Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone. [PDF]
J Clin PharmacolCipriano A +5 more
europepmc +1 more source
Paravertebral blocks and enhanced recovery after surgery protocols in breast reconstructive surgery: Patient selection and perspectives [PDF]
, 2018 Myckatyn, Terence M, Parikh, Rajiv P
core +1 more source
Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl. [PDF]
Addict Sci Clin PractStein BD +4 more
europepmc +1 more source
NARCOTIC ANTAGONIST ACTIVITY OF THE 3-PHENYL-PIPERIDINES WITH N-ANTAGONISTIC SUBSTITUTION
, 1973 Seiichi Nurimoto, Goro Hayashi
openalex +1 more source
Characteristics and Trends of Prehospital Encounters for Opioid Overdoses Among US Youth, 2018-2022.
JAMALim JK +4 more
europepmc +1 more source
Major Gaps in the Cascade of Care for Opioid Use Disorder: Implications for Clinical Practice. [PDF]
JAMAArwady MA, Delphin-Rittmon M, Volkow ND.
europepmc +1 more source
Empowering Future Physicians: Enhancing Naloxone Competency Through Early Harm Reduction Training in Medical Education. [PDF]
MedEdPORTALOvalles Lacruz A +5 more
europepmc +1 more source
Reversing effects of narcotic antagonists to narcotic immobilizing agents in zoo animals.
, 1986 Etsuo NARUSHIMA
openalex +2 more sources